Ask AI
ProCE Banner Events

Share

Virtual Skills Lab in ET and PV: Bridging Diagnostic Gaps, Advancing Prognosis, and Preparing for Emerging Therapies

Join us for this interactive, CME/EBAH-certified live webinar featuring global expert perspectives on diagnosis, prognosis, and novel therapies for essential thrombocythemia (ET) and polycythemia vera (PV). Be sure to bring your questions for the live Q&A session with the expert panel.

Physicians: maximum of 1.00 AMA PRA Category 1 Credit™

Who Should Attend

This activity is intended for hematologists and other healthcare professionals caring for patients with essential thrombocythemia and polycythemia vera.

Time and location

Thursday, December 18, 2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Agenda

  • PV and ET Diagnosis: The Importance of Diagnostic Bone Marrow Biopsies and Assessing the Risk of Thrombotic Events
  • Understanding Prognostic Scoring Systems in ET and PV, Including Prognostic Immune Biomarkers
  • Empowering Patients in ET and PV: Skills-Based Strategies to Strengthen Shared Decision-making and Treatment Alignment
  • Preparing for Practice Change: Integrating Novel Agents and Next-generation Interferons in ET and PV Management
  • Audience Q&A

CME/CE Info

Goal Statement
This activity will equip learners’ to recognize, diagnose, and stratify risk in patients with ET and PV, while preparing clinical practices to integrate emerging second-line therapies. By strengthening early identification of MPN-related thrombotic events, applying dynamic prognostic models, and improving shared decision-making, the program supports timely, patient-aligned care to reduce complications and improve outcomes.

Target Audience
This activity is intended for hematologists and other healthcare professionals caring for patients with essential thrombocythemia and polycythemia vera.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Identify underlying MPNs such as ET and PV in patients presenting with thrombotic events that are otherwise unexplained
  • Diagnose patients with ET and PV, including bone marrow biopsies and assessment of risk of thrombotic events
  • Determine prognoses for individual patients with ET and PV using prognostic scoring system and identification of immune biomarkers
  • Engage patients with ET and PV in shared-decision making to better align treatment with both best practices and patient preferences on risks and benefits
  • Prepare clinical practice to incorporate new second-line agents for ET and PV upon approval

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC

Supporter

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.